<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>§ 48–902.08. Schedule III enumerated. | D.C. Law Library</title>
    <meta name="generator" content="Open Law Library v2018.10.0"/>
    <link rel="shortcut icon" href="/us/dc/_document/v1/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta name="description" content="Browse the laws and code of the District of Columbia"/>
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/dc/council/code/titles/48/chapters/9/index.full.html"/>
    <meta itemprop="toc-json" content="/dc/council/code/titles/48/chapters/9/index.json"/>
    <meta itemprop="parent-doc-url" content="/dc/council/code/"/>
    <meta itemprop="doc-type" content="section"/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://code.dccouncil.us/dc/council/code/sections/48-902.08.html"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="§ 48–902.08. Schedule III enumerated. | D.C. Law Library"/>
    <meta property="og:image" content="http://code.dccouncil.us/us/dc/_document/v1/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="msapplication-config" content="/browserconfig.xml"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Council of the District of Columbia"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="msapplication-navbutton-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/dc/_document/v1/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/dc/_document/v1/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/dc/_document/v1/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/dc/_document/v1/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/dc/_document/v1/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/dc/_document/v1/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/dc/_document/v1/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/dc/_document/v1/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/dc/_document/v1/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/dc/_document/v1/biticons/biticons.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v1/fonts/droid-serif/droid-serif.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v1/fonts/open-sans/open-sans.css" type="text/css" rel="stylesheet"/>
    <!--Document CSS-->
    <link href="/us/dc/_document/v1/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v1/styles/main.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v1/styles/print.min.css" type="text/css" rel="stylesheet" media="print"/>
    <script src="/_reader/js/main.js"> </script>
    <!--Search-->
    <script type="text/javascript">
      window.searchHost = "https://search.code.dccouncil.us";
      window.queryUrl = "/v1/search";
    </script>
    <script type="text/javascript">
        var _paq = _paq || [];
        _paq.push(['trackPageView']);
        _paq.push(['enableLinkTracking']);
        (function() {
            var u="//analytics.code.dccouncil.us/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', 1]);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
        })();
    </script>
  </head>
  <body>
    <a href="#area__content" class="skip-link">Skip to main content</a>
    <div id="grid-dc">
      <header id="grid-dc__header">
        <section id="grid-dc__header__small">
          <div id="grid-dc__header__small__inner"> </div>
        </section>
        <section id="grid-dc__header__large">
          <div id="grid-dc__header__large__inner">
            <section id="area__logo" class="ns__document__us-dc">
              <!--Logo-->
              <a href="/#" class="logo" alt="Council of the District of Columbia">
                <img src="/us/dc/_document/v1/images/logo/dc-seal-outline.png" srcset="/us/dc/_document/v1/images/logo/dc-seal-outline.png 1x, /us/dc/_document/v1/images/logo/dc-seal-outline@2x.png 2x" alt="Council of the District of Columbia logo"/>
              </a>
            </section>
            <section id="area__main_title" class="ns__document__us-dc">
              <a href="/">
                <img src="/us/dc/_document/v1/images/logo/dccouncil_typemark.svg" alt="Council of the District of Columbia logotype"/>
              </a>
            </section>
          </div>
        </section>
      </header>
      <div id="grid-dc__main">
        <section id="area__breadcrumbs" class="ui ns__document__us-dc" role="region">
          <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-hidden="true" aria-label="Mobile menu toggler"/>
          <label for="menu-trigger" aria-label="Toggle mobile menu"> </label>
          <nav role="navigation" aria-label="Breadcrumb navigation">
            <div class="h__ui">Navigation</div>
            <ul class="ancestors">
              <li data-search-path="library" data-search-heading="All Documents" class="no-icon">
                <a href="/">D.C. Law Library</a>
              </li>
              <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code" data-search-default="true">
                <a href="/dc/council/code/">Code of the District of Columbia</a>
              </li>
              <li data-search-path="library|D.C. Code|48" data-search-heading="Title 48">
                <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a>
              </li>
              <li data-search-path="library|D.C. Code|48|9" data-search-heading="Chapter 9">
                <a href="/dc/council/code/titles/48/chapters/9/">Chapter 9. Controlled Substances Act.</a>
              </li>
              <li data-search-path="library|D.C. Code|48|9|II" data-search-heading="Subchapter II">
                <a href="/dc/council/code/titles/48/chapters/9/subchapters/II/">Subchapter II. Standards and Schedules.</a>
              </li>
              <li data-search-path="library|D.C. Code|48|9|II|48-902.08" data-search-heading="§ 48-902.08">
                <span>§ 48–902.08. Schedule III enumerated.</span>
              </li>
            </ul>
          </nav>
        </section>
        <main id="area__content" class="ns__document__us-dc">
          <h1 class="h__toc" id="/dc/council/code/sections/48-902.08.html">§ 48–902.08. Schedule III enumerated.</h1>
          <article class="content" role="document">
            <!--Content section-->
            <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> The controlled substances listed in this section are included in Schedule III, unless and until removed therefrom pursuant to <a class="no-wrap" href="/dc/council/code/sections/48-902.01.html">§ 48-902.01</a>:</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(1)">(1)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(A)">(A)</span> Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under § 1308.32 of the Code of Federal Regulations, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(B)">(B)</span> Benzphetamine;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(C)">(C)</span> Chlorphentermine;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(D)">(D)</span> Chlortermine;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(E)">(E)</span> Mazindol; and</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(1)(F)">(F)</span> Phendimetrazine;</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(2)">(2)</span> Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(2)(A)">(A)</span> Any compound, mixture, or preparation containing:</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(A)(i)">(i)</span> Amobarbital;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(A)(ii)">(ii)</span> Secobarbital; or</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(A)(iii)">(iii)</span> Pentobarbital; or any salt thereof and 1 or more other active medicinal ingredients which are not listed in any schedule;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(2)(B)">(B)</span> Any suppository dosage form containing:</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(B)(i)">(i)</span> Amobarbital;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(B)(ii)">(ii)</span> Secobarbital;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(B)(iii)">(iii)</span> Pentobarbital; or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(2)(C)">(C)</span> Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid:</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(i)">(i)</span> Chlorhexadol;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(ii)">(ii)</span> Rescheduled to Schedule II;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(iii)">(iii)</span> Lysergic acid;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(iv)">(iv)</span> Lysergic acid amide;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(v)">(v)</span> Methyprylon;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(vi)">(vi)</span> Sulfondiethylmethane;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(vii)">(vii)</span> Sulfonethylmethane;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(viii)">(viii)</span> Sulfonmethane;</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(ix)">(ix)</span> Tiletamine &amp; Zolazepam Combination Product; and</p>
            <p class="text-indent-4"><span class="level-num" id="(a)(2)(C)(x)">(x)</span> Vinbarbital;</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(3)">(3)</span> Nalorphine;</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(4)">(4)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(A)">(A)</span> Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(B)">(B)</span> Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(C)">(C)</span> Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a 4-fold or greater quantity of an isoquinoline alkaloid of opium;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(D)">(D)</span> Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(E)">(E)</span> Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(F)">(F)</span> Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with 1 or more ingredients in recognized therapeutic amounts;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(G)">(G)</span> Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts; and</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(4)(H)">(H)</span> Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(5)">(5)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, drug, or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progesterons, and corticorsteroids) that promotes muscle growth and includes:</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(A)">(A)</span> Boldenone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(B)">(B)</span> Chlortestosterone (4-chlortestosterone);</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(C)">(C)</span> Clostebol;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(D)">(D)</span> Dehydrochlormethyltestosterone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(E)">(E)</span> Dihydrotestosterone (4-dihydrotestosterone);</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(F)">(F)</span> Drostanolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(G)">(G)</span> Ethylestrenol;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(H)">(H)</span> Fluoxymestorone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(I)">(I)</span> Formebulone (formebolone);</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(J)">(J)</span> Mesterolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(K)">(K)</span> Methandienone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(L)">(L)</span> Methandranone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(M)">(M)</span> Methandriol;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(N)">(N)</span> Methandrostenolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(O)">(O)</span> Methenolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(P)">(P)</span> Methyltestosterone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(Q)">(Q)</span> Mibolerone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(R)">(R)</span> Nandrolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(S)">(S)</span> Norethandrolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(T)">(T)</span> Oxandrolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(U)">(U)</span> Oxymesterone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(V)">(V)</span> Oxymetholone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(W)">(W)</span> Stanolone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(X)">(X)</span> Stanozolol;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(Y)">(Y)</span> Testolactone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(Z)">(Z)</span> Testosterone;</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(AA)">(AA)</span> Trenbolone; and</p>
            <p class="text-indent-3"><span class="level-num" id="(a)(5)(BB)">(BB)</span> Any salt, ester or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth. Except such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by Secretary of Health and Human Services for such administration. If any person prescribes, dispenses or distributes such steroid for human use such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph; and</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(6)">(6)</span> Cannabis.</p>
            <p class="text-indent-2"><span class="level-num" id="(a)(7)">(7)</span> Repealed.</p>
            <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The Mayor may except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in paragraphs (1) and (2) of subsection (a) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains 1 or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.</p>
            <aside class="annotations" role="note">
              <p>
      (<a href="/dc/council/laws/4-29.html#§208" title="§ 208.">Aug. 5, 1981, D.C. Law 4-29, § 208, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; amended by rule Dec. 7, 1994, 41 DCR 7967; <a href="/dc/council/laws/13-300.html" title="D.C. Law 13-300. Distribution of Marijuana Amendment Act of 2000.">June 8, 2001, D.C. Law 13-300, § 2(a), 47 DCR 7037</a>; <a href="/dc/council/laws/19-320.html" title="D.C. Law 19-320. Omnibus Criminal Code Amendments Act of 2012.">June 19, 2013, D.C. Law 19-320, § 301(d), 60 DCR 3390</a>; <a href="/dc/council/laws/22-243.html#§2(c)" title="">Mar. 13, 2019, D.C. Law 22-243, § 2(c), 66 DCR 937</a>.)
    </p>
              <h4>Prior Codifications</h4>
              <p>1981 Ed., § 33-518.</p>
              <h4>Section References</h4>
              <p>This section is referenced in <a class="no-wrap" href="/dc/council/code/sections/7-3002.html">§ 7-3002</a>, <a class="no-wrap" href="/dc/council/code/sections/44-1201.html">§ 44-1201</a>, <a class="no-wrap" href="/dc/council/code/sections/48-853.01.html">§ 48-853.01</a>, <a class="no-wrap" href="/dc/council/code/sections/48-902.01.html">§ 48-902.01</a>, <a class="no-wrap" href="/dc/council/code/sections/48-902.02.html">§ 48-902.02</a>, and <a class="no-wrap" href="/dc/council/code/sections/48-1004.html">§ 48-1004</a>.</p>
              <h4>Effect of Amendments</h4>
              <p><a class="" href="/dc/council/laws/13-300.html">D.C. Law 13-300</a>, in subsec. (a), deleted “and” at the end of par. (4)(H), substituted “; and” for the period at the end of par. (5)(BB), and added par. (6).</p>
              <p>The 2013 amendment by <a class="" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (a)(7); and made related changes.</p>
              <h4>Emergency Legislation</h4>
              <p>
                <a class="internal-link" href="/dc/council/acts/22-550.html#§2(c)" title="">For temporary (90 days) amendment of this section, see <a class="" href="/dc/council/acts/22-550.html#§2(c)">§ 2(c) of Revised Synthetics Abatement and Full Enforcement Drug Control Congressional Review Emergency Amendment Act of 2018 (D.C. Act 22-550, Dec. 26, 2018, 66 DCR 225)</a>.</a>
              </p>
              <p>
                <a class="internal-link" href="/dc/council/acts/22-464.html#§2(c)" title="">For temporary (90 days) amendment of this section, see <a class="" href="/dc/council/acts/22-464.html#§2(c)">§ 2(c) of Revised Synthetics Abatement and Full Enforcement Drug Control Emergency Amendment Act of 2018 (D.C. Act 22-464, Oct. 5, 2018, 65 DCR 11377)</a>.</a>
              </p>
              <p>For temporary amendment of (a), see § 301(d) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</p>
              <p>For temporary (90 days) amendment of this section, see § 301(d) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</p>
              <h4>Temporary Legislation</h4>
              <p>
                <a class="internal-link" href="/dc/council/laws/22-204.html#§2(c)" title="">For temporary (225 days) amendment of this section, see <a class="" href="/dc/council/laws/22-204.html#§2(c)">§ 2(c) of Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2018 (D.C. Law 22-204, Feb. 22, 2019, 65 DCR 12338)</a>.</a>
              </p>
              <p>
                <a class="internal-link" href="/dc/council/laws/21-131.html#§2(c)" title="">For temporary (225 days) amendment of this section, see <a class="" href="/dc/council/laws/21-131.html#§2(c)">§ 2(c) of Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016 (D.C. Law 21-131, July 1, 2016, 63 DCR 7110)</a>.</a>
              </p>
            </aside>
            <hr class="section-separator" aria-hidden="true"/>
          </article>
        </main>
        <nav id="area__navigation_mini" class="ui ns__document__us-dc" role="region" aria-label="Previos and next article links">
          <section>
            <a href="/dc/council/code/sections/48-902.07.html" aria-label="§ 48–902.07. Schedule III tests.">
              <div class="h__ui">Previous</div>
              <span>§ 48–902.07. Schedule III tests.</span>
            </a>
          </section>
          <section>
            <a href="/dc/council/code/sections/48-902.09.html" aria-label="§ 48–902.09. Schedule IV tests.">
              <div class="h__ui">Next</div>
              <span>§ 48–902.09. Schedule IV tests.</span>
            </a>
          </section>
        </nav>
      </div>
      <footer id="grid-dc__footer">
        <div id="grid-dc__footer__inner">
          <section id="footer__logo" class="ns__document__us-dc">
            <!--Logo-->
            <a href="/#" class="logo" alt="Council of the District of Columbia">
              <img src="/us/dc/_document/v1/images/logo/dc-seal.png" srcset="/us/dc/_document/v1/images/logo/dc-seal.png 1x, /us/dc/_document/v1/images/logo/dc-seal@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </section>
          <section id="footer__content" class="ns__document__us-dc" role="region">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
          </section>
        </div>
      </footer>
      <!--Piwik analytics-->
      <noscript>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </noscript>
    </div>
  </body>
</html>
